
https://www.science.org/content/blog-post/not-100-not-really
# Not Really. (April 2015)

## 1. SUMMARY
This article discusses the broader problem of scientific hype and lack of honesty in synthetic organic chemistry reporting. The author references concerns raised by Tomas Hudlicky regarding questionable practices in chemistry literature, specifically highlighting a Journal of Organic Chemistry (JOC) paper from a South Korean research group claiming a total synthesis of brazilin where six reactions purportedly achieved 100% yields. The author argues that such yields are essentially impossible given standard workup and chromatography procedures, as shown by empirical demonstrations that even known compounds cannot be recovered to 100% through typical purification processes. The article frames inflated yield reporting as a symptom of a larger systemic issueâ€”hyping results, self-deception, and the casual acceptance of unrealistic claims in scientific literature. The author suggests that scientific integrity requires honest reporting even in small details, as the same tendencies that tolerate minor exaggerations can lead to more serious misconduct.

## 2. HISTORY
**Research Integrity and Replication Crisis Developments:** Following this 2015 article, the broader scientific community experienced growing awareness of reproducibility and research integrity issues. Chemistry and other experimental sciences saw intensified scrutiny of results reporting practices, though progress has been mixed and incremental. The scientific publishing landscape has made some progress toward improved reporting standards, but deep systemic issues persist.

**Yield Reporting Practices in Organic Synthesis:** Throughout the remainder of the 2010s and into the 2020s, synthetic chemistry has continued to grapple with yield inflation and selective reporting. While some journals have tightened guidelines for experimental reporting, particularly for supporting information, current yield reporting practices still show signs of the issues highlighted in 2015. Studies and systematic analyses published since 2015 have continued to document unrealistic yield distributions and insufficient reporting of reaction conditions.

**Hudlicky's Ongoing Impact:** Hudlicky's critiques, which the article references, reflected broader concerns that have gained increasing traction but have not yet resulted in fundamental reform to how experimental organic chemistry results are reported.

**No Direct Clinical or Commercial Impact:** Unlike articles discussing specific drug candidates or therapeutic strategies, this methodological critique has no direct path to clinical outcomes or commercial products. Its impact lies in the realm of scientific practice and publication ethics, where changes occur slowly and cultural shifts are gradual. The article does not discuss biotechnology applications or drug development programs that could lead to FDA approvals or clinical adoption.

## 3. PREDICTIONS
The article is primarily focused on current (2015) problems and does not contain explicit forward-looking predictions. The concerns raised apply to ongoing structural issues in scientific reporting rather than forecasting future developments. While the article implies that systemic problems will persist without reform, it lacks specific predictions about how organic synthesis or research integrity would evolve in subsequent years.

## 4. INTEREST
Rating: **4/10**

This article addresses a real and persistent methodological issue in chemical synthesis, highlighting important concerns about research integrity and reproducibility that have broader relevance beyond this specific field. However, for a general audience or those interested in biotechnology applications and their real-world impacts, the topic has limited relevance. The discussion focuses on academic chemistry practices without connecting to clinical outcomes, therapeutic discoveries, or commercial developments that characterize higher-impact biotechnology coverage. The article's value is primarily in its critique of scientific practice rather than clinical applications or drug development.


----
_model_params = {'model': 'nex-agi/deepseek-v3.1-nex-n1:free', 'input': '20150409-not-100-not-really.txt', 'reasoning': {'effort': 'high'}, 'text': {'verbosity': 'medium'}, 'prompt-template': 'prompt-template-2'}_